SCHEMBL17680433

SCHEMBL17680433

NC(=O)c1c(B(O)O)[nH]c2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2 P11137 2/20 0.45
KDM4E B2RXH2 3/20 0.45
TDP1 Q9NUW8 1/20 0.45
ALDH1A1 P00352 4/20 0.42
ATM Q13315 1/20 0.42
NR4A2 P43354 2/20 0.41
PIM1 P11309 1/20 0.41
PIM3 Q86V86 1/20 0.41
KMT2A Q03164 2/20 0.41
MITF O75030 1/20 0.41
LMNA P02545 1/20 0.41
RAB9A P51151 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
PDGFRB P09619 1/20 0.40
KDR P35968 1/20 0.40
EGFR P00533 2/20 0.40
MEN1 O00255 1/20 0.40
SRC P12931 1/20 0.40
GPR3 P46089 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18824256 0.77 MAP2 (0.62) MAP2KDM4ETDP1ALDH1A1ATM
SCHEMBL3203918 0.77 KDM4E (0.49) MAP2KDM4ETDP1ALDH1A1ATM
SCHEMBL10596909 0.77 KDM4E (0.49) MAP2KDM4ETDP1ALDH1A1ATM
SCHEMBL3788709 0.75 GABRA1 (0.49) KDM4ETDP1ALDH1A1NR4A2KMT2A
SCHEMBL29050101 0.75 MEN1 (0.61) MAP2KDM4ETDP1ALDH1A1KMT2A
SCHEMBL3624515 0.75 NR4A2 (0.65) KDM4EALDH1A1NR4A2KMT2AMITF
SCHEMBL29025503 0.75 MAP2 (0.47) MAP2KDM4ETDP1ALDH1A1ATM
SCHEMBL721793 0.74 MAP2 (0.58) MAP2KDM4ETDP1ALDH1A1KMT2A
SCHEMBL6857314 0.72 MAP2 (0.45) MAP2KDM4ETDP1ALDH1A1ATM
SCHEMBL4120335 0.71 ALDH1A1 (0.57) KDM4ETDP1ALDH1A1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9403803-B2 Indole-3-carboxamides as kinase inhibitors ALLERGAN, INC. (US) 2016-08-02 US disclosed
US-9403803-B2 Indole-3-carboxamides as kinase inhibitors ALLERGAN, INC. (US) 2016-08-02 US disclosed
US-20160102077-A1 Indole-3-Carboxamides as Kinase Inhibitors ALLERGAN, INC. 2016-04-14 US disclosed
US-20160102077-A1 Indole-3-Carboxamides as Kinase Inhibitors ALLERGAN, INC. 2016-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160102077-A1 Indole-3-Carboxamides as Kinase Inhibitors JAK2, REN, IGF1R MAP2 619/4885KDM4E 460/4885TDP1 3680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.